There is currently an urgent need to develop efficient gene-delivery systems for the lung that are free of inflammatory effects. The LID vector is a synthetic gene delivery system, comprised of ...

HIV-derived lentiviral vectors are efficient vehicula to deliver genes into the brain and hold great promise for future gene therapy of neurodegenerative disorders. However, administration of the ...

Researchers have developed a new and improved viral vector -- a virus-based vehicle that delivers therapeutic genes -- for use in gene therapy for sickle cell disease. In advanced lab tests using ...

Researchers at the National Institutes of Health (NIH) have developed a unique, improved viral vector to use in gene therapy for sickle cell disease. Using animal models, the new vector was shown to ...

A radically redesigned viral vector may improve the delivery of therapeutic genes to patients with sickle-cell disease. According to tests in animal models, the new vector is up to ten times more ...

This is the CBSE Class 12th Chapter, Vector Algebra. Experts of Jagranjosh.com offer the best practice material that covers all important questions so that students will not miss any portion while ...

As the competition is increasing day by day in Joint Entrance Examination (Main and Advanced), it is very necessary for engineering aspirants to cover all topics in each subject. But it is impossible ...

Manufacturers must address scale-out challenges of autologous cell therapy for commercial manufacturing. Although only a few cell-therapy treatments have regulatory approval, recent years have seen a ...

Researchers at the National Institutes of Health (NIH) have developed a new and improved viral vector--a virus-based vehicle that delivers therapeutic genes--for use in gene therapy for sickle cell ...

A novel and improved viral vector for use in gene therapy in sickle cell disease has been developed by National Institutes of Health (NIH) researchers. In advanced lab tests using animal models, the ...

Researchers at the National Institutes of Health have developed a new and improved viral vector a virus-based vehicle that delivers therapeutic genes for use in gene therapy for sickle cell disease.